What is the main business of Polmedico?

The main business activity of Polmedico focuses on wholesale of pharmaceutical goods.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on December 8, 2023.

Where is the headquarters located?

The headquarters is located at: ul. Nowogrodzka 50/54, 00-695 Warszawa.

What is the share capital?

The share capital of the company is PLN 5,000 (approx. $1,351).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.

What was the revenue?

The company reported a revenue of $53,999 in 2025, which is an increase of 54.7% compared to 2024.

Yes, in 2025 the company was profitable, achieving a net profit of $6,940, meaning the company increased its profit by 319.4%.

Which cost dominates operating expenses?

The largest operating cost category falls under cost of goods and materials sold. This category amounted to $34,869 in 2025, representing 77% of all operating expenses.

Polmedicosp. z o.o.

Wholesale of pharmaceutical goods

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2023-12-08

Share capital

5 000,00 PLN

Registered address

ul. Nowogrodzka 50/54/515, 00-695 Warszawa, Poland

Financials

Revenue history (in k)

Filing timeliness

1 of 2 financial statements was filed late (for 2024, 98 days late).

202518/06/2026
202421/10/2025

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue

This companyUSD 54.00kMedianUSD 1.06mAverageUSD 22.41m

Net profit

This companyUSD 6.94kMedianUSD 37.20kAverageUSD 879.46k

Operating costs

This companyUSD 45.09kMedianUSD 921.66kAverageUSD 21.08m

Assets

This companyUSD 16.85kMedianUSD 609.79kAverageUSD 11.85m

Industry

Authorized Representatives

Attaallh Alrefaee – Management Board Member

M.ayman Aziza – President of the Management Board

Mohamad Rafiaa Dabbagh – Management Board Member

Mariusz Henryk Pajduszewski – Attorney-in-fact (sole)

Michał Turkowski – Attorney-in-fact (sole)

Manner of representation

Each member of the management board is authorized to make declarations on behalf of the company independently.

Ownership

Owner	Shares	Share value	Stake
Attaallh Alrefaee	15	$405.19	30%
M.ayman Aziza	20	$540.25	40%
Mohamad Rafiaa Dabbagh	15	$405.19	30%

Beneficial owners

Person	Rights

Bank accounts

Registered as a VAT taxpayer on 2024-01-15.

Bank Millennium
04 1160 2202 0000 0005 9510 6111
Bank Millennium
66 1160 2202 0000 0005 9510 0436

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Name	Revenue	Website
Vorwarts Pharmasp. z o.o.	$210,138.62	vorwartspharma.pl
Black & Whitesp. z o.o.	$154,866.36	polonus.pl
Osteoprofsp. z o.o.	$72,065.80	osteoprof.pl
THC PharmaS.A.	$39,093.70	thc-pharma.pl
EDGE Pharmasp. z o.o.	$19,855.64	edgepharma.eu
Arcade Internationalsp. z o.o.	$17,817.26	arcade-int.pl
Filicosp. z o.o.	$11,710.75	filico.eu
Get Ready Wheelchairssp. z o.o.	$9,842.54	getreadywheelchairs.com
Jacek Waksmundzki Trust 2S.K.A.	$5,769.53	trust.pl
Optimedussp. z o.o.	$1.00	optimedus.pl